Table 3

Results will be summarised in table format

Study characteristicsPatients’ characteristicsIn-hospital complicationsSix-month outcomeTwelve-month outcome
Lead author, title and year of publication, journal, study design, setting and location, sample size and length of follow-up.Age, ethnicity, obstetric history, comorbidities, clinical presentation, electrocardiography, echocardiography, biomarkers and treatment.Death, arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism), LV assist device, pacemaker, invasive ventilation, acute kidney injury.Death, readmission to hospital, LV non-recovery (persistent LV dilatation and/or LVEF <50%), arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism).Death, readmission to hospital, LV non-recovery (persistent LV dilatation and/or LVEF <50%), arrhythmias (eg, AF, VT) or thromboembolism (eg, DVT, PE, LV thrombus, stroke, arterial embolism).
  • AF, atrial fibrillation; DVT, deep vein thrombosis; LV, left ventricular; LVEF, LV ejection fraction; PE, pulmonary embolism; VT, ventricular tachycardia.